NDC 82619-114 – Silodosin
Silodosin 8 mg/1 · Capsule · Oral
Product NDC82619-114
Product details
- Brand name
- Silodosin
- Generic name
- Silodosin
- Labeler
- Creekwood Pharmaceuticals LLC
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA213230
- Marketed since
- November 14, 2024
- Listing expires
- December 31, 2027
- Pharmacologic class
- alpha-Adrenergic Blocker
Active ingredients
- Silodosin 8 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 82619-114-01 | 30 CAPSULE in 1 BOTTLE (82619-114-01) | Nov 14, 2024 |
| 82619-114-02 | 90 CAPSULE in 1 BOTTLE (82619-114-02) | Nov 14, 2024 |
Other Silodosin products
- 27241-144 Silodosin 4 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 27241-145 Silodosin 8 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 62332-406 Silodosin 8 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 62332-405 Silodosin 4 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 46708-405 Silodosin 4 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 46708-406 Silodosin 8 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 69238-1420 Silodosin 8 mg/1 · Capsule · Amneal Pharmaceuticals NY LLC
- 60219-1421 Silodosin 4 mg/1 · Capsule · Amneal Pharmaceuticals NY LLC
- 69238-1421 Silodosin 4 mg/1 · Capsule · Amneal Pharmaceuticals NY LLC
- 60219-1420 Silodosin 8 mg/1 · Capsule · Amneal Pharmaceuticals NY LLC
- 59651-095 Silodosin 4 mg/1 · Capsule · Aurobindo Pharma Limited
- 59651-096 Silodosin 8 mg/1 · Capsule · Aurobindo Pharma Limited